April 20, 2021
Pyxis Oncology Hosting Key Opinion Webinar on Antibody-Drug Conjugates
Webinar on Tuesday, April 27th @ 1pmETCAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Pyxis Oncology (“Pyxis” or the “Company”)…
Pharmaceuticals, Biotechnology and Life Sciences
Webinar on Tuesday, April 27th @ 1pmETCAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Pyxis Oncology (“Pyxis” or the “Company”)…
LAS VEGAS, NV, April 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — One World Pharma Inc. (OTC: OWPC), (“OWP” or…
TurboCAR Technology Allows a Programmable Cytokine Signaling to Potentially Control T Cell Exhaustion and Improve Function and Potency of AlloCAR…
Study quantified coronary plaque changes in patients administered 4 g/day of VASCEPA® (icosapent ethyl) on top of statin therapy Effect…
Secondary endpoint data for once-nightly FT218 further supports previously announced topline data demonstrating clinically meaningful results at 6 g, 7.5…
COPENHAGEN, Denmark, April 17, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following…
TORONTO, April 16, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”),…
10 accepted abstracts include five oral presentations from pioneering artificial intelligence (AI) collaboration Presentations support the potential of intravitreal pegcetacoplan,…
SAN JOSE, Calif., April 16, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)…
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares…